<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04967066</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-07-06</org_study_id>
    <nct_id>NCT04967066</nct_id>
  </id_info>
  <brief_title>A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures</brief_title>
  <official_title>Serum Levels of Adipocytokines in Children With Febrile Seizures: A Cross-Sectional Study at Sohag University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Febrile seizure (FS) is a common neurological condition in children, affecting 2 - 14% of&#xD;
      children. FS is defined as seizures occurring in a child aged from six months to five years&#xD;
      that is accompanied by a fever (≥38°C) without central nervous system infection. FS is&#xD;
      classified into simple febrile seizure (SFS) and complex febrile seizure (CFS). SFS accounts&#xD;
      for 70-75% of FS cases and is characterized by being generalized, duration of less than 15&#xD;
      minutes, occurs once in 24 hours, and no previous neurologic problems. We aim to investigate&#xD;
      serum levels of adipocytokines, specifically leptin, adiponectin, and IL-6, in children with&#xD;
      FS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include three groups of children (100 for each): children with febrile&#xD;
      seizures (group 1), febrile children without seizures (group 2), and healthy control children&#xD;
      (group 3). Children included in this study will undergo:&#xD;
&#xD;
        -  Thorough medical history taking: including age, gender, and seizure details for children&#xD;
           with febrile seizures (e.g., type, duration, recurrence).&#xD;
&#xD;
        -  Physical examination: including vital signs (particularly temperature) and comprehensive&#xD;
           neurological examination).&#xD;
&#xD;
        -  Laboratory investigations:&#xD;
&#xD;
             -  Routine investigations: complete blood count, C-reactive protein, blood glucose,&#xD;
                serum electrolytes (sodium, potassium, calcium, and magnesium), liver and kidney&#xD;
                function tests.&#xD;
&#xD;
             -  Serum leptin, adiponectin, and IL6: venous blood samples (3 ml) will be obtained&#xD;
                from children with FS (within 3 hours of seizures) as well as the two control&#xD;
                groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The&#xD;
                serum will be immediately separated and stored at -70 ℃. Serum leptin, adiponectin,&#xD;
                and IL6 will be assessed through enzyme-linked immunosorbent assay (ELISA) kits&#xD;
                according to the manufacturer's instructions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>3 Weeks</target_duration>
  <primary_outcome>
    <measure>Serum leptin</measure>
    <time_frame>within 3 hours of seizures</time_frame>
    <description>venous blood samples (3 ml) will be obtained from children with FS as well as the two control groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum leptin will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum adiponectin</measure>
    <time_frame>within 3 hours of seizures</time_frame>
    <description>venous blood samples (3 ml) will be obtained from children with FS as well as the two control groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum adiponectin will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum IL6</measure>
    <time_frame>within 3 hours of seizures</time_frame>
    <description>venous blood samples (3 ml) will be obtained from children with FS as well as the two control groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum IL6 will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Febrile Seizure</condition>
  <arm_group>
    <arm_group_label>children with febrile convulsions</arm_group_label>
    <description>Inclusion criteria&#xD;
Age from 6 months to 6 years.&#xD;
Seizures.&#xD;
Fever (≥38°C).&#xD;
Exclusion criteria&#xD;
Central nervous system infection.&#xD;
Epilepsy.&#xD;
Previous neurological abnormalities.&#xD;
Inborn errors of metabolism.&#xD;
Immunological diseases.&#xD;
Endocrinal diseases (e.g., diabetes mellitus).&#xD;
Obesity.&#xD;
Eating disorders.&#xD;
Gastrointestinal disorders (e.g., diarrhea).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Febrile children without convulsions</arm_group_label>
    <description>Inclusion criteria&#xD;
Age from 6 months to 6 years.&#xD;
Fever (≥38°C) due to acute infection.&#xD;
Exclusion criteria&#xD;
Seizures.&#xD;
Central nervous system infection.&#xD;
Previous neurological abnormalities.&#xD;
Inborn errors of metabolism.&#xD;
Immunological diseases.&#xD;
Endocrinal diseases (e.g., diabetes mellitus).&#xD;
Obesity.&#xD;
Eating disorders.&#xD;
Gastrointestinal disorders (e.g., diarrhea).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control children</arm_group_label>
    <description>Inclusion criteria&#xD;
Age from 6 months to 6 years.&#xD;
Presented for routine check-up.&#xD;
Exclusion criteria&#xD;
Fever.&#xD;
Seizures.&#xD;
Central nervous system infection.&#xD;
Previous neurological abnormalities.&#xD;
Inborn errors of metabolism.&#xD;
Immunological diseases.&#xD;
Endocrinal diseases (e.g., diabetes mellitus).&#xD;
Obesity.&#xD;
Eating disorders.&#xD;
Gastrointestinal disorders (e.g., diarrhea).&#xD;
Any illness in the last month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum Levels of Adipocytokines</intervention_name>
    <description>Serum leptin, adiponectin, and IL6: venous blood samples (3 ml) will be obtained from children with FS (within 3 hours of seizures) as well as the two control groups. Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum leptin, adiponectin, and IL6 will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions.</description>
    <arm_group_label>Febrile children without convulsions</arm_group_label>
    <arm_group_label>Healthy control children</arm_group_label>
    <arm_group_label>children with febrile convulsions</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be&#xD;
      immediately separated and stored at -70 ℃. Serum leptin, adiponectin, and IL6 will be&#xD;
      assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the&#xD;
      manufacturer's instructions.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Chi-square test will be used in comparing qualitative data between two groups, and Fisher&#xD;
        exact test will be used instead of the Chi-square test when the expected count in any cell&#xD;
        is less than 5. Student's T-test will be used in the comparison between two groups with&#xD;
        quantitative data and parametric distribution, and Mann-Whitney test will be used in the&#xD;
        comparison between two groups with quantitative data and non-parametric distribution.&#xD;
        One-way analysis of variance (ANOVA) and Kruskal-Wallis tests will be used to compare more&#xD;
        than two independent groups for quantitative data with parametric and non-parametric&#xD;
        distribution, respectively. Pearson's and Spearman's correlation will be used to test the&#xD;
        correlation analysis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 6 months to 6 years.&#xD;
&#xD;
          -  Seizures.&#xD;
&#xD;
          -  Fever (≥38°C) due to acute infection.&#xD;
&#xD;
          -  Presented for routine check-up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Central nervous system infection.&#xD;
&#xD;
          -  Epilepsy.&#xD;
&#xD;
          -  Previous neurological abnormalities.&#xD;
&#xD;
          -  Inborn errors of metabolism.&#xD;
&#xD;
          -  Immunological diseases.&#xD;
&#xD;
          -  Endocrinal diseases (e.g., diabetes mellitus).&#xD;
&#xD;
          -  Obesity.&#xD;
&#xD;
          -  Eating disorders.&#xD;
&#xD;
          -  Gastrointestinal disorders (e.g., diarrhea).&#xD;
&#xD;
          -  Seizures.&#xD;
&#xD;
          -  Previous neurological abnormalities&#xD;
&#xD;
          -  Any illness in the last month&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdelrahim A. Sadek, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdelhady R. Abdel-Gawad, Lecturer</last_name>
    <role>Study Chair</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elsayed M. Abdelkreem, Lecturer</last_name>
    <role>Study Chair</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hagar A. Mohamed, M.B.B.Ch</last_name>
    <phone>+201000414711</phone>
    <email>hagerabdelhameed@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag University Hospitals</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hagar A. Mohamed, M.B.B.Ch</last_name>
      <phone>+201000414711</phone>
      <email>hagerabdelhameed@med.sohag.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>July 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Hagar Abdelhamid Mohamed</investigator_full_name>
    <investigator_title>Resident of Pediatrics, Sohag University Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Seizures, Febrile</mesh_term>
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

